Tag: CLSN

Blue Horseshoe Stocks: AAPL Options & More

Lumber Liquidators Holdings Inc. LL – Recap
Although LL did gap up a lot higher than expected to start the session, and larger gains would have been available at higher strike prices closer to the money, but most of our listed targets, the LL Weekly $27.50-29.50 Calls, still managed to see some solid intraday moves.

Those potential gains, including a double-bagger by the $28’s, were as follows:

$27.50 Calls – Range: 3.00-5.50 – Max Gain: 83%
$28 Calls – Range: 2.30-5.00 – Max Gain: 117%
$28.50 Calls – Range: 3.36-4.27 – Max Gain: 27%
$29 Calls – Range: 2.00-3.70 – Max Gain: 85%

Apple, Inc. AAPL

With AAPL breaking out to new all-time highs in the premarket this morning, after a strong earnings report was more than enough to assuage any concerns about lagging iPhone sales, we’re going to want to try to get in on the fun.

AAPL is gearing up to the point that it may also drive the DOW to the 22,000 level, causing a cascading effect that should make for an interesting week for traders across the board.

As for us, we’re going to be tracking the AAPL Weekly $155-162.50 Calls on the heels of this premarket mega-push that has thus far yielded a high of $160 on the nose.

Amarin Corp plc AMRN

We also want to take note of AMRN, which recently took a fair beating on the chart, and is showing clear signs of a reversal.

We also want to signal some calls in that options chain as well as watching the stock itself. The AMRN Weekly $4 Calls will be the options we put on our radar.

Extended Watchlist:
SRMX, STBV, RWLK, CLSN, CLDX, OGXI, MTW

Blue Horseshoe Stocks: PIXY Review & More

ShiftPixy, Inc. PIXY

As we were mentioning on Monday morning, we included PIXY in Friday’s report on its first ever trading day. Generally speaking we don’t tend to cast our lot in with brand new IPO’s, but a trusted source in our network gave us a heads-up on PIXY, and didn’t let us down.

We of course passed it along to our readers immediately in our premarket report on Friday, and the stock, after two trading days has made some really nice progress.

From the initial opening price of 6.30 we observed in PIXY, it went on to hit a high of 9.70 to kick off the short trading week on Monday. That marks a two-day swing of 54% for this newly-trading juggernaut. We’ll continue to be on the lookout for PIXY to keep recording higher base levels of support.

Opexa Therapeutics, Inc. OPXA

An honorable mention from Monday’s report is OPXA, especially considering that sessions just prior to a holiday break are typically low-key affairs.

The stock put up a solid intraday performance, running 35% from a low of a dollar up to 1.35, and pulling back into the close at 1.15. However, premarket activity this morning has seen the stock trade back to just below Monday’s high. This is one we’ll want to keep on our radar for the time being.

Aphria, Inc. APHQF

We’ve been familiar with APHQF for quite a time, but today will be the first occasion we’ve actually mentioned it in our reports.

Today, we wanted to point out that the company released two PR’s yesterday, the more significant of which was the announcement of a 1-year cannabis supply deal with a licensed Canadian medical provider which will bring upwards of $5M in revenue beginning midway through next year. We’ll provide links to both PR’s so you can check them out for yourself.

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer – 07/04

Tokyo Smoke to open Canadian flagship retail store on Queen Street West – 07/04

Extended Watchlist:
OTTV, CLSN, MSDI, MTBC, TOPS, GBR, FCEL

Blue Horseshoe Stocks: EKSO New Highs & More

Ekso Bionics Holdings, Inc. EKSO

What started as a nominal gainer that came off of our extended watchlist on Wednesday, EKSO rolled its 37% performance over into yesterday’s session, carrying on the multiday action. After a  strong close at 1.81 on Thursday, we said we’d be interested in continuing to track EKSO as we head into week’s end, and it was a great idea.

The stock continued its ascent to a new high  and reached 2.18. From Wednesday’s low of 1.40, it works out to a respectable two day swing of 56% Just as we mentioned yesterday, the stock closed strong again, and we’ll want to keep monitoring for higher highs and higher lows .

Valeant Pharmaceuticals, Inc. VRX – Options Idea

Valeant has been working its way down to an area of relative support recently, consolidating after a nice run off of its 52-week lows from April to May. This morning in the premarket, we’ve taken notice of the fact that VRX is gapping up considerably in the premarket.

We want to be waiting in the wings with an options idea to take advantage of the action following what could very well be an early dip-and-rip formation. We’ve called VRX and a ton of other such stocks in these positions, and done very well in the past.

We’ll be looking to the VRX Weekly $12 and 12.50 Calls* for possible swing trades today.

*We never include mentions of weekly options contracts on a Friday without explicitly warning our readers that trading weekly options at the end of the week is a hugely risky proposition that should not be attempted unless you are an expert trader! 

Ampio Pharmaceuticals, Inc. AMPE

We want to point out a possible momentum play in AMPE. We’ve talked about this stock in the past, and as you can see from the included chart snapshot, it has been mounting a decent rebound effort off of a double bottom over the past few sessions.

We’re going to place AMPE on watch into next week, as a similar move to the one exhibited by the stock earlier this spring would mean considerable gains from this point.

Extended Watchlist:
HOS, MYO, CLSN, TAUG, GAHC, BTSC